Canada Life’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $345K | Hold |
13,434
| – | – | ﹤0.01% | 1536 |
|
|
2026
Q1 | $259K | Hold |
13,434
| – | – | ﹤0.01% | 1569 |
|
|
2025
Q4 | $222K | Hold |
13,434
| – | – | ﹤0.01% | 1605 |
|
|
2025
Q3 | $195K | Hold |
13,434
| – | – | ﹤0.01% | 1693 |
|
|
2025
Q2 | $188K | Hold |
13,434
| – | – | ﹤0.01% | 1704 |
|
|
2025
Q1 | $183K | Hold |
13,434
| – | – | ﹤0.01% | 1728 |
|
|
2024
Q4 | $274K | Hold |
13,434
| – | – | ﹤0.01% | 1719 |
|
|
2024
Q3 | $392K | Hold |
13,434
| – | – | ﹤0.01% | 1721 |
|
|
2024
Q2 | $312K | Buy |
13,434
+3,710
| +38% | +$71.2K | ﹤0.01% | 1768 |
|
|
2024
Q1 | $200K | Hold |
9,724
| – | – | ﹤0.01% | 1830 |
|
|
2023
Q4 | $207K | Hold |
9,724
| – | – | ﹤0.01% | 1841 |
|
|
2023
Q3 | $200K | Buy |
9,724
+5,400
| +125% | +$137K | ﹤0.01% | 1859 |
|
|
2023
Q2 | $128K | Sell |
4,324
-318
| -7% | -$8.94K | ﹤0.01% | 1892 |
|
|
2023
Q1 | $107K | Hold |
4,642
| – | – | ﹤0.01% | 1970 |
|
|
2022
Q4 | $130K | Hold |
4,642
| – | – | ﹤0.01% | 1938 |
|
|
2022
Q3 | $142K | Hold |
4,642
| – | – | ﹤0.01% | 1932 |
|
|
2022
Q2 | $137K | Buy |
4,642
+768
| +20% | +$20.1K | ﹤0.01% | 1874 |
|
|
2022
Q1 | $132K | Sell |
3,874
-588
| -13% | -$20.2K | ﹤0.01% | 1940 |
|
|
2021
Q4 | $198K | Hold |
4,462
| – | – | ﹤0.01% | 1873 |
|
|
2021
Q3 | $226K | Hold |
4,462
| – | – | ﹤0.01% | 1885 |
|
|
2021
Q2 | $350K | Sell |
4,462
-441
| -9% | -$27.3K | ﹤0.01% | 1815 |
|
|
2021
Q1 | $277K | Sell |
4,903
-1,141
| -19% | -$76.4K | ﹤0.01% | 1866 |
|
|
2020
Q4 | $504K | Hold |
6,044
| – | – | ﹤0.01% | 1748 |
|
|
2020
Q3 | $216K | Hold |
6,044
| – | – | ﹤0.01% | 1886 |
|
|
2020
Q2 | $145K | Hold |
6,044
| – | – | ﹤0.01% | 1969 |
|
|
2020
Q1 | $107K | Hold |
6,044
| – | – | ﹤0.01% | 1965 |
|
|
2019
Q4 | $104K | Buy |
+6,044
| New | +$101K | ﹤0.01% | 2066 |
|
|
2019
Q3 | – | Sell |
-6,503
| Closed | -$135K | – | 1435 |
|
|
2019
Q2 | $135K | Sell |
6,503
-901
| -12% | -$20.2K | ﹤0.01% | 2128 |
|
|
2019
Q1 | $171K | Hold |
7,404
| – | – | ﹤0.01% | 1915 |
|
|
2018
Q4 | $147K | Hold |
7,404
| – | – | ﹤0.01% | 2020 |
|
|
2018
Q3 | $161K | Buy |
+7,404
| New | +$122K | ﹤0.01% | 2048 |
|
Other funds holding DNLI
Canada Life's DNLI Position: Q2 2026 in Review
Canada Life held its Denali Therapeutics (DNLI) position steady in Q2 2026 at 13,434 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #1536.
Canada Life first reported a position in DNLI in Q3 2018 and has held it in 31 quarters since. The position peaked at $504K in Q4 2020. 294 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.
- Canada Life held 13,434 shares of Denali Therapeutics worth $345K as of Q2 2026.
- Canada Life left its Denali Therapeutics share count unchanged in Q2 2026.
- Denali Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1536 holding.
- Canada Life first reported a position in Denali Therapeutics in Q3 2018 and has held it in 31 quarters since.
- Canada Life's Denali Therapeutics position peaked at $504K in Q4 2020.
- 294 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.
Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.